Newly-released Branched Stent Graft Market industry analysis report by Future Market Insights shows that global sales of the Branched Stent Graft Market in 2021 were held at US$ 335.8 Million. With a CAGR of 8.5% from 2022 to 2032, the market is projected to reach a valuation of US$ 814 Million by 2032. The market is projected to witness the largest revenue through the ChiMillioney application which is expected to grow at a CAGR of 9.3% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Branched Stent Graft Market (2022) | US$ 361 Million |
| Global Branched Stent Graft Market (2032) | US$ 814 Million |
| Global Branched Stent Graft Market CAGR (2022 to 2032) | 8.5% |
| USA Branched Stent Graft Market (2022) | 7.6% |
| Key Companies Profiled | Medtronic; Biotronik; Alvimedica; Endocor GmbH; Eucatech AG; Merit Medical Systems; Abbott; Cook Medical; Cardinal Health; Boston Scientific Corp.; Terumo Corp. |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Branched Stent Graft Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value increased at around 7.1% CAGR, wherein, countries such as the USA, UK, China, Japan, and South Korea held a significant share in the global market.
The global branched stent grafts are used in a variety of EVAR (endovascular aneurysm repair) operations. Because of lower rates of morbidity and mortality, EVAR for significant aortic diseases such as aneurysms, traumatic ruptures, and dissections has acquired universal surgeon and patient acceptability. Over the forecast period, this trend is expected to fuel the demand in the global branching stent grafts market. The global branching stent grafts market is also growing due to rising cases of cardiovascular illnesses and the wider acceptance of stenting operations.
The placement of a stent graft within the human vasculature is a minimally invasive surgery used to treat aortic aneurysms and dissections. After a pigtail catheter and guide wires are inserted, a shaft catheter with a foldable stent or stent graft is used to cover the lesion.
The physician must check that the stent graft is properly positioned inside the vascular tree before unfolding it. Misplacements of covered stent grafts might result in a partial or complete cut-off of blood flow to crucial organs. An endoleak is a serious complication that occurs when blood leaks between the stent graft and the aneurysm sac.
Principal Consultant
The prevalence of aortic aneurysms is predicted to rise as the global old population grows, contributing to market growth throughout the forecast period. Aortic aneurysms were the main cause of mortality in the USA in 2018, accounting for 9,923 deaths. Aortic aneurysms include thoracic and abdominal aortic aneurysms, as well as aneurysms in other areas of the body.
Medtronic is a medical device manufacturer that specializes in stent grafts. A recently approved stent graft apparatus allows researchers to study using endograft for fenestrated aneurysm repair for patients suffering from a type of abdominal aortic aneurysm located close to the organ those branches off to the internal organs. For patients who lack the proximity necessary for conventional endovascular aneurysm repair, a fenestrated endograft is used.
With a CAGR of more than 10% over the projection period, the market in Asia Pacific is expected to grow at the fastest pace. This expansion might be attributed to growing healthcare spending and the rapidly expanding medical tourism industry in the Asia Pacific area. Developing economies such as China, Japan, India, and Australia make up the APAC regional market. The presence of higher-quality healthcare infrastructure, convenience, and cheap treatment alternatives in these nations is also likely to drive regional market expansion.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Because of its well-established healthcare infrastructure, presence of multiple competitors, and favorable reimbursement coverage, North America is expected to hold the greatest share of the worldwide branching stent grafts market in the future years. Because of the strong presence of numerous established and well-trained industry competitors, it is expected that the global branching stent grafts market in North America will face tough rivalry in the future years.
By 2021, the USA will continue to account for the largest share of the global branching stent grafts market, however, there are worries about device availability, particularly in addressing difficult indications. The market in the country is projected to reach US$ 320 Million by 2032. Numerous devices that are currently approved in other countries, such as fenestrated stent grafts, are currently being administered in medical trials in the USA, disallowing medical practitioners from using systems that have a broad scope of applications.
The market in the UK is projected to reach a valuation of US$ 37 Million by 2032. Growing at a CAGR of 11.1% from 2022 to 2032, the market is expected to gross an absolute dollar opportunity of US$ 24 Million.
In Japan, the market is expected to reach US$ 29.2 Million by 2032. Growing at a CAGR of 9.4%, the market is projected to garner an absolute dollar opportunity of US$ 17.4% during the forecast period.
The market in South Korea is projected to register US$ 14.4 Million by 2032, growing at a CAGR of 10.1% from 2022 to 2032. During the forecast period, the market is expected to gross an absolute dollar opportunity of US$ 8.8 Million.
Branched stent grafts are commonly used in EVAR treatments. EVAR is divided into the chimney, Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR), and various sub-categories. Recent advancements in branched stent grafts have made it possible to treat a variety of aortic aneurysms, including those involving the visceral arteries.
Some of the key players in the branched stent graft market include Medtronic, Biotronik, Alvimedica, Endocor GmbH, Eucatech AG, Merit Medical Systems, Abbott, Cook Medical, Cardinal Health, Boston Scientific Corp., and Terumo Corp.
Some of the recent developments of key players in the Branched Stent Graft Market are as follows:
Similarly, recent developments related to companies offering Branched Stent Graft have been tracked by the team at Future Market Insights, which are available in the full report.
The global market is worth more than US$ 361.3 Million at present.
The market value is projected to increase at a CAGR of around 8.5% from 2022 to 2032.
The market value increased at a CAGR of around 7.1% from 2017 to 2021.
With a projected CAGR of 8.7% during the forecast period, the Iliac Stent segment dominated the Branched Stent Graft industry.
The top 5 countries driving demand for Branched Stent Graft Market are the USA., UK, China, Japan, and South Korea.
Because of its well-established healthcare infrastructure, presence of multiple major competitors, and favorable reimbursement coverage, North America is expected to hold the greatest share of the global branching stent grafts market in the future years
The UK market for Branched Stent Grafts is projected to expand at a CAGR of around 11.1% from 2022 to 2032.
While the market in South Korea is expected to grow at nearly 10.1%, the market in Japan is projected to register a CAGR of nearly 9.4% from 2022 to 2032.
1. Executive Summary | Branched Stent Graft Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Investment Feasibility Matrix 3.4. Regulatory Landscape 3.4.1. By Key Regions 3.4.2. By Key Countries 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2022 to 2032 5.3.1. Iliac Stent 5.3.2. Other Types 5.3.3. Manual Beds 5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032 6.3.1. FEVAR 6.3.2. ChiMillioney 6.3.3. Other EVARs 6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia 7.3.6. Oceania 7.3.7. Middle East and Africa (MEA) 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. United States of America 8.2.1.2. Canada 8.2.2. By Type 8.2.3. By Application 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.3.3. By Application 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Argentina 9.2.1.4. Rest of Latin America 9.2.2. By Type 9.2.3. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By Application 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. Italy 10.2.1.3. France 10.2.1.4. United Kingdom 10.2.1.5. Spain 10.2.1.6. Russia 10.2.1.7. BENELUX 10.2.1.8. Rest of Europe 10.2.2. By Type 10.2.3. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Application 10.4. Key Takeaways 11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Type 11.2.3. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Application 11.4. Key Takeaways 12. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Thailand 12.2.1.3. Malaysia 12.2.1.4. Indonesia 12.2.1.5. Rest of South Asia 12.2.2. By Type 12.2.3. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Application 12.4. Key Takeaways 13. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Type 13.2.3. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Application 13.4. Key Takeaways 14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. Rest of MEA 14.2.2. By Type 14.2.3. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Application 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. United States of America 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Type 15.1.2.2. By Application 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Type 15.2.2.2. By Application 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Type 15.3.2.2. By Application 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Type 15.4.2.2. By Application 15.5. Argentina 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Type 15.5.2.2. By Application 15.6. Germany 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Type 15.6.2.2. By Application 15.7. Italy 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Type 15.7.2.2. By Application 15.8. France 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Type 15.8.2.2. By Application 15.9. United Kingdom 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Type 15.9.2.2. By Application 15.10. Spain 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Type 15.10.2.2. By Application 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Type 15.11.2.2. By Application 15.12. BENELUX 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Type 15.12.2.2. By Application 15.13. China 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Type 15.13.2.2. By Application 15.14. Japan 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Type 15.14.2.2. By Application 15.15. South Korea 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Type 15.15.2.2. By Application 15.16. India 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Type 15.16.2.2. By Application 15.17. Thailand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Type 15.17.2.2. By Application 15.18. Malaysia 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Type 15.18.2.2. By Application 15.19. Indonesia 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Type 15.19.2.2. By Application 15.20. Australia 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Type 15.20.2.2. By Application 15.21. New Zealand 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2021 15.21.2.1. By Type 15.21.2.2. By Application 15.22. GCC Countries 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2021 15.22.2.1. By Type 15.22.2.2. By Application 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Type 16.3.3. By Application 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Medtronic 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. Biotronik 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Alvimedica 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Endocor GmbH 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Eucatech AG 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Merit Medical Systems 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Abbott 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Cook Medical 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. Cardinal Health 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Boston Scientific Corp. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. Terumo Corp. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Branched Stent Graft Market
